AtaGenix Laboratories
AtaGenix Laboratories
Release time: 2026-01-08 View volume: 62
AtaGenix proudly exhibits at the American Association for Cancer Research® (AACR) Annual Meeting 2026—the leading global platform for cancer discovery and innovation. With 14 years of expertise and trusted by over 3,000 partners worldwide, we provide end-to-end, customized R&D services and catalog reagents for oncology studies.Visit Booth #1761 to accelerate your immune-oncology, biomarker, and therapeutic programs.
We deliver tailored, high-yield custom protein and antibody platforms optimized for every stage of oncology drug discovery and development.
Key capabilities include:
Over 10,000 recombinant proteins and 20,000+ antibodies with rigorous lot-to-lot consistency (CV <10%)—ideal for reproducible ADC screening, bispecific development, and high-throughput oncology studies.
Key oncology lines:
With state-of-the-art facilities and deep oncology expertise, AtaGenix and abinScience provide reliable, high-performance solutions from discovery through IND-enabling studies—accelerating your path from bench to clinic.
Booth #1761
Discover custom protein/antibody solutions and abinScience catalog reagents in the Exhibit Hall.
Exhibits Open: April 19–22, 2026
Location: San Diego Convention Center, California
Let’s accelerate cancer breakthroughs together. Share with #AACR26!
Contact Us:
For inquiries or to schedule a meeting:
www.atagenix.com (Services) | www.abinscience.com (Products)
AtaGenix is an Official Exhibitor of the AACR Annual Meeting 2026.
All materials are subject to AACR guidelines and should be submitted to exhibits@aacr.org for approval if required.
Contact Us
+86-27-87001869
info@atagenix.com
Building C, R & D Building, No. 666, Shendun 4th Road, Donghu New Technology Development Zone, Wuhan
